Interventional Radiology In Brief
This article was originally published in The Gray Sheet
Executive Summary
Embolization/RF ablation for liver cancer: Combining minimally-invasive embolization and ablation is as effective as surgery for treating single tumors up to 7 cm in diameter, according to a study abstract presented by Anne Covey, MD, Memorial Sloan Kettering Cancer Center, at the Society of Interventional Radiology annual scientific meeting March 25-30 in Phoenix. Although patients with more advanced liver cancer were treated with the combined treatment, survival rates at one, two, four and five years were 97%, 83%, 77% and 56% compared with 81%, 70%, 70% and 57% for the surgery group. Boston Scientific (Contour SE) and BioSphere Medical (Embosphere Microspheres) are among the firms offering embolization devices, and Boston Scientific (RF 3000), Tyco (Cool-tip) and Rita Medical (Starburst) market RF ablation systems...
You may also be interested in...
Rita Medical To Triple Revenue, U.S. Sales Force With Horizon Merger
Rita Medical Systems' $112.4 mil. stock purchase of Horizon Medical Products will appreciably expand the firm's direct sales reach, particularly in rural areas
Rita Medical To Triple Revenue, U.S. Sales Force With Horizon Merger
Rita Medical Systems' $112.4 mil. stock purchase of Horizon Medical Products will appreciably expand the firm's direct sales reach, particularly in rural areas
Carotid Screening Data To Be Unveiled In February, Following AAA Bill
Carotid artery disease screening cost-effectiveness data are being generated by a coalition of vascular surgeons and manufacturers to support the case for a Medicare screening benefit